Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Helicobacter pylori test-and-eradicate strategy versus early endoscopy in patients with dyspepsia

Nature Clinical Practice Gastroenterology & Hepatology volume 2, pages 70–71 (2005)Cite this article

boxed-textLassen AT et al. (2004) Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7 year follow up of a randomised trial. Gut 53: 1758–1763

Helicobacter pylori test-and-eradicate is an appropriate strategy for the long-term management of dyspepsia

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Delaney BC et al. (2003) Initial management strategies for dyspepsia. Cochrane Database Syst Rev 2: CD001961

    Google Scholar 

  2. Ford AC et al. (2004) The long-term natural history of dyspepsia, the importance of irritable bowel syndrome (abstract). Gastroenterology 126: A439

    Google Scholar 

  3. Sreedharan A et al. (2004) Cost-effectiveness and long-term impact of Helicobacter pylori “test and treat” service in reducing open access endoscopy referrals. Eur J Gastroenterol Hepatol 16: 981–986

    Article  Google Scholar 

  4. Ford AC et al. (2004) Prompt endoscopy versus a “test and treat” strategy in the initial management of dyspepsia: an individual patient data meta-analysis of randomized controlled trials (abstract). Gastroenterology 126: A70

    Google Scholar 

  5. National Institute of Clinical Excellence (2004). Dyspepsia: management of dyspepsia in adults in primary care. [http://www.nice.org.uk/pdf/CG017NICEguideline.pdf] (accessed 5 December 2004)

Download references

Acknowledgements

The synopsis was written by Minal Chande, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor of Gastroenterology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada

    Paul Moayyedi

Authors
  1. Paul Moayyedi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul Moayyedi.

Ethics declarations

Competing interests

Paul Moayyedi has received consulting fees from AstraZeneca, Wyeth Laboratories and Takeda, all of which are companies that make PPI therapies. His Chair is in part funded by an unrestricted donation from AstraZeneca to McMaster University.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moayyedi, P. Helicobacter pylori test-and-eradicate strategy versus early endoscopy in patients with dyspepsia. Nat Rev Gastroenterol Hepatol 2, 70–71 (2005). https://doi.org/10.1038/ncpgasthep0091

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0091

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing